PeptidePub Blog

Research findings, pricing news, and vendor analysis across the peptide market.

Posts about Tirzepatide

Showing 1 to 6 of 6

ResearchSeptember 18, 202610 min read

Best GLP-1 for Women Over 40: What Actually Works

Hormonal shifts after 40 make weight loss harder. GLP-1 medications can help — but the research on women specifically tells a different story than the headlines.

ResearchJune 20, 20269 min read

Do GLP-1 Drugs Raise or Lower Cancer Risk?

The current evidence does not show a broad human cancer-risk increase from GLP-1 drugs, and some studies suggest lower risk for obesity-related cancers. This explainer separates thyroid-label warnings, pancreatic-cancer fears, observational signals, and what the data cannot prove.

ResearchMay 6, 202610 min read

Do You Need to Diet and Exercise on GLP-1 Medications?

GLP-1s work without strict dieting — but the research shows that adding protein and resistance training dramatically improves results and prevents muscle loss.

ResearchMay 6, 20269 min read

GLP-1 Medications for PCOS: What the Research Shows

PCOS affects 1 in 10 women and is driven by insulin resistance. GLP-1 medications target that root cause — and the early research is promising.

ResearchMarch 28, 20264 min read

Beyond Weight Loss: What New Research Reveals About GLP-1 Drugs

New research from the Technical University of Munich and Harvard Medical School reveals that semaglutide and tirzepatide don't just promote weight loss — they appear to fundamentally reshape the body's metabolic and inflammatory pathways in ways researchers didn't fully anticipate.

ResearchMarch 28, 20263 min read

Ozempic Linked to Reduced Depression, Anxiety, and Addiction Risk — What the New Data Shows

New research from the University of Eastern Finland has found that semaglutide (Ozempic/Wegovy) is associated with significantly reduced rates of depression, anxiety, and substance use disorders — adding to a growing body of evidence that GLP-1 drugs do far more than cause weight loss.

STOP PIECING IT TOGETHER

One article at a time is a slow way to learn peptides.

We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.

Get the Handbook30-day money-back guarantee. Free updates for life.